论文部分内容阅读
前列腺癌是男性生殖系统常见的恶性肿瘤,为欧美国家发病率较高的肿瘤,目前在我国前列癌发病率较低,但近年来随着人口老龄化加剧及生活条件的改善,发病率有明显增加的趋势[1]。前列腺特异抗原(prostate specific antigen,PSA)是临床筛选、早期发现前列腺癌及疗效随访最有意义的血清标志物,同时也是预测良性前列腺增生疾病进展的重要指标,但由于正常前列腺组织、前列腺增生组织和前列腺癌组织均可产生PSA,并且PSA水平受年龄、种
Prostate cancer is a common malignant tumor of the male reproductive system, is a high incidence of cancer in Europe and the United States, the incidence of prostate cancer in our country is low, but in recent years as the population aging and living conditions improve, the incidence was significant Increasing trend [1]. Prostate specific antigen (PSA) is the most important serum marker for clinical screening, early detection of prostate cancer and follow-up of curative effect. It is also an important index for predicting the progress of benign prostatic hyperplasia. However, due to the abnormality of normal prostate, benign prostatic hyperplasia And prostate cancer tissue can produce PSA, and PSA levels by age, species